DUBLIN–(BUSINESS WIRE)–The “Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering.
This report provides comprehensive information about the Synthetic Bone Graft Substitutes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Synthetic bone graft substitutes are used as substitutes to autograft and allograft bone.
Scope
- Extensive coverage of the Synthetic Bone Graft Substitutes under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
2 Introduction
3 Products under Development
3.1 Synthetic Bone Graft Substitutes – Pipeline Products by Stage of Development
3.2 Synthetic Bone Graft Substitutes – Pipeline Products by Territory
3.3 Synthetic Bone Graft Substitutes – Pipeline Products by Regulatory Path
3.4 Synthetic Bone Graft Substitutes – Pipeline Products by Estimated Approval Date
3.5 Synthetic Bone Graft Substitutes – Ongoing Clinical Trials
4 Synthetic Bone Graft Substitutes – Pipeline Products under Development by Companies
4.1 Synthetic Bone Graft Substitutes Companies – Pipeline Products by Stage of Development
4.2 Synthetic Bone Graft Substitutes – Pipeline Products by Stage of Development
5 Synthetic Bone Graft Substitutes Companies and Product Overview
5.1 Acuitive Technologies Inc Company Overview
5.2 Agenta Biotechnologies Inc (Inactive) Company Overview
5.3 Amend Surgical, Inc. Company Overview
5.4 Anika Therapeutics Inc Company Overview
5.5 Baxter International Inc Company Overview
5.6 Berkeley Advanced Biomaterials Inc Company Overview
5.7 Bio2 Technologies Inc Company Overview
5.8 BioGend Therapeutics Co Ltd Company Overview
5.9 Biomatlante SA Company Overview
5.10 Biorez Inc Company Overview
5.11 BonAlive Biomaterials Ltd. Company Overview
5.12 Bone Solutions Inc Company Overview
5.13 BoneGrafix, Inc. Company Overview
5.14 BoneSupport AB Company Overview
5.15 Calcitec, Inc. Company Overview
5.16 Daewoong Pharmaceutical Co Ltd Company Overview
5.17 Dimension Inx LLC Company Overview
5.18 DSM Biomedical BV Company Overview
5.19 Elute Inc Company Overview
5.20 Eskisehir Osmangazi University Company Overview
5.21 EternoGen Aesthetics LLC Company Overview
5.22 Graftys SA Company Overview
5.23 Industrie Biomediche Insubri SA Company Overview
5.24 Innovoss Inc. (Inactive) Company Overview
5.25 IRCCS San Raffaele Hospital Company Overview
5.26 Isto Biologics Company Overview
5.27 King’s College London Company Overview
5.28 Maxigen Biotech Inc Company Overview
5.29 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview
5.30 National University of Science and Technology MiSiS Company Overview
5.31 OrthoMedex LLC Company Overview
5.32 PolyPid Ltd Company Overview
5.33 Polytechnic University of Catalonia Company Overview
5.34 Promimic AB Company Overview
5.35 ReCaPP Company Overview
5.36 RepRegen Ltd. (Inactive) Company Overview
5.37 Revivicor Inc Company Overview
5.38 Sanara MedTech Inc Company Overview
5.39 Scil Technology GmbH Company Overview
5.40 SDIP Innovations Pty Ltd Company Overview
5.41 SIRAKOSS Ltd Company Overview
5.42 Sofregen Medical Inc Company Overview
5.43 Soteira Inc Company Overview
5.44 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.45 SurGenTec LLC Company Overview
5.46 University of California San Diego Company Overview
5.47 University of Edinburgh Company Overview
5.48 Wright Medical Group NV Company Overview
5.49 Xtant Medical Holdings Inc Company Overview
6 Synthetic Bone Graft Substitutes- Recent Developments
7 Appendix
Companies Mentioned
- Acuitive Technologies Inc
- Agenta Biotechnologies Inc (Inactive)
- Amend Surgical, Inc.
- Anika Therapeutics Inc
- Baxter International Inc
- Berkeley Advanced Biomaterials Inc
- Bio2 Technologies Inc
- BioGend Therapeutics Co Ltd
- Biomatlante SA
- Biorez Inc
- BonAlive Biomaterials Ltd.
- Bone Solutions Inc
- BoneGrafix, Inc.
- BoneSupport AB
- Calcitec, Inc.
- Daewoong Pharmaceutical Co Ltd
- Dimension Inx LLC
- DSM Biomedical BV
- Elute Inc
- Eskisehir Osmangazi University
- EternoGen Aesthetics LLC
- Graftys SA
- Industrie Biomediche Insubri SA
- Innovoss Inc. (Inactive)
- IRCCS San Raffaele Hospital
- Isto Biologics
- King’s College London
- Maxigen Biotech Inc
- National Center of Innovation for Biomaterials in Orthopaedic Research
- National University of Science and Technology MiSiS
- OrthoMedex LLC
- PolyPid Ltd
- Polytechnic University of Catalonia
- Promimic AB
- ReCaPP
- RepRegen Ltd. (Inactive)
- Revivicor Inc
- Sanara MedTech Inc
- Scil Technology GmbH
- SDIP Innovations Pty Ltd
- SIRAKOSS Ltd
- Sofregen Medical Inc
- Soteira Inc
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- SurGenTec LLC
- University of California San Diego
- University of Edinburgh
- Wright Medical Group NV
- Xtant Medical Holdings Inc
For more information about this report visit https://www.researchandmarkets.com/r/r1m45h
Source: GlobalData
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
